RZLT
Rezolute Inc
NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY
$3.20
+2.56% today
Updated 2026-04-30
Market cap
$293.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$1 – $11
Volume
2.4M
Rezolute Inc (RZLT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-40398.00 | $-1.63M | $-3.17M | $-7.08M | $-10.49M | $-13.31M | $-14.11M | $-15.30M | $-24.17M | $-20.44M | $-39.62M | $-44.48M | $-57.37M | $-69.08M |
| Capital expenditures | $2000.00 | $11717.00 | $69974.00 | $3.16M | $2.09M | $407929.00 | $5816.00 | $47000.00 | $153000.00 | $153000.00 | $153000.00 | $153000.00 | $0.00 | $0.00 |
| Depreciation | $221.00 | $295.00 | $11303.00 | $134125.00 | $751254.00 | $1.11M | $1.07M | $49000.00 | $18000.00 | $13000.00 | $13000.00 | $30000.00 | $36000.00 | $31000.00 |
| Stock-based comp | — | $3.69M | $1.08M | $2.85M | $3.76M | $6.01M | $5.10M | $2.64M | $3.32M | $3.96M | $3.69M | $7.27M | $7.36M | $7.12M |
| Free cash flow | $-42398.00 | $-1.64M | $-3.24M | $-10.24M | $-12.58M | $-13.72M | $-14.12M | $-15.35M | $-24.32M | $-20.59M | $-39.77M | $-44.63M | $-57.37M | $-69.08M |
| Investing cash flow | $-2000.00 | $185114.00 | $-830185.00 | $-3.61M | $-1.45M | $-195383.00 | $1.73M | $231000.00 | $-101.46M | $-101.46M | $-101.46M | $-101.46M | $48.70M | $-14.54M |
| Financing cash flow | $10500.00 | $1.42M | $9.93M | $10.04M | $10.73M | $13.93M | $9.54M | $25.00M | $22.55M | $51.53M | $148.98M | $11.57M | $63.03M | $107.33M |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | $109.36M | — | — | — |